164 related articles for article (PubMed ID: 36875549)
1. Ferroptosis: friend or foe in cancer immunotherapy?
Demuynck R; Efimova I; Catanzaro E; Krysko DV
Oncoimmunology; 2023; 12(1):2182992. PubMed ID: 36875549
[TBL] [Abstract][Full Text] [Related]
2. A nanoformulation for immunosuppression reversal and broad-spectrum self-amplifying antitumor ferroptosis-immunotherapy.
Yang Q; Liu T; Zheng H; Zhou Z; Huang Y; Jia H; Fu S; Zhang X; Zhang H; Liu Y; Chen X; Shan W
Biomaterials; 2023 Jan; 292():121936. PubMed ID: 36502663
[TBL] [Abstract][Full Text] [Related]
3. Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity.
Efimova I; Catanzaro E; Van der Meeren L; Turubanova VD; Hammad H; Mishchenko TA; Vedunova MV; Fimognari C; Bachert C; Coppieters F; Lefever S; Skirtach AG; Krysko O; Krysko DV
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188036
[TBL] [Abstract][Full Text] [Related]
4. Diabetic Ferroptosis and Pancreatic Cancer: Foe or Friend?
Li L; Yu XJ; Gao L; Cheng L; Sun B; Wang G
Antioxid Redox Signal; 2022 Dec; 37(16-18):1206-1221. PubMed ID: 35996983
[No Abstract] [Full Text] [Related]
5. Immunogenic ferroptosis and where to find it?
Demuynck R; Efimova I; Naessens F; Krysko DV
J Immunother Cancer; 2021 Dec; 9(12):. PubMed ID: 34903554
[TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin elicits immunogenic death through ferroptosis-triggered ER stress and DNA damage for lung cancer immunotherapy.
Han N; Yang ZY; Xie ZX; Xu HZ; Yu TT; Li QR; Li LG; Peng XC; Yang XX; Hu J; Xu X; Chen X; Wang MF; Li TF
Phytomedicine; 2023 Apr; 112():154682. PubMed ID: 36739636
[TBL] [Abstract][Full Text] [Related]
7. Acidity-Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of Cancer.
Song R; Li T; Ye J; Sun F; Hou B; Saeed M; Gao J; Wang Y; Zhu Q; Xu Z; Yu H
Adv Mater; 2021 Aug; 33(31):e2101155. PubMed ID: 34170581
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance.
Liu T; Zhu C; Chen X; Guan G; Zou C; Shen S; Wu J; Wang Y; Lin Z; Chen L; Cheng P; Cheng W; Wu A
Neuro Oncol; 2022 Jul; 24(7):1113-1125. PubMed ID: 35148413
[TBL] [Abstract][Full Text] [Related]
9. Iron-based nanoscale coordination polymers synergistically induce immunogenic ferroptosis by blocking dihydrofolate reductase for cancer immunotherapy.
Yu Y; Huang Z; Chen Q; Zhang Z; Jiang H; Gu R; Ding Y; Hu Y
Biomaterials; 2022 Sep; 288():121724. PubMed ID: 36038420
[TBL] [Abstract][Full Text] [Related]
10. Evoking Highly Immunogenic Ferroptosis Aided by Intramolecular Motion-Induced Photo-Hyperthermia for Cancer Therapy.
Chen C; Wang Z; Jia S; Zhang Y; Ji S; Zhao Z; Kwok RTK; Lam JWY; Ding D; Shi Y; Tang BZ
Adv Sci (Weinh); 2022 Apr; 9(10):e2104885. PubMed ID: 35132824
[TBL] [Abstract][Full Text] [Related]
11. Ferroptosis: Promising approach for cancer and cancer immunotherapy.
Zheng S; Guan XY
Cancer Lett; 2023 May; 561():216152. PubMed ID: 37023938
[TBL] [Abstract][Full Text] [Related]
12. Tumor neutrophils ferroptosis: a targetable immunosuppressive mechanism for cancer immunotherapy.
Du S; Zeng F; Deng G
Signal Transduct Target Ther; 2023 Feb; 8(1):77. PubMed ID: 36813764
[No Abstract] [Full Text] [Related]
13. Immunogenic cell death related risk model to delineate ferroptosis pathway and predict immunotherapy response of patients with GBM.
Feng S; Liang X; Li J; Wang Z; Zhang H; Dai Z; Luo P; Liu Z; Zhang J; Xiao X; Cheng Q
Front Immunol; 2022; 13():992855. PubMed ID: 36248827
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of dihydroartemisinin and pyropheophorbide-iron elicits ferroptosis to potentiate cancer immunotherapy.
Han W; Duan X; Ni K; Li Y; Chan C; Lin W
Biomaterials; 2022 Jan; 280():121315. PubMed ID: 34920370
[TBL] [Abstract][Full Text] [Related]
15. A Triple Therapeutic Strategy with Antiexosomal Iron Efflux for Enhanced Ferroptosis Therapy and Immunotherapy.
Wang Y; Chen Q; Song H; Zhang Y; Chen H; Liu P; Sun T; Jiang C
Small; 2022 Oct; 18(41):e2201704. PubMed ID: 36071027
[TBL] [Abstract][Full Text] [Related]
16. CD8
Wang W; Green M; Choi JE; Gijón M; Kennedy PD; Johnson JK; Liao P; Lang X; Kryczek I; Sell A; Xia H; Zhou J; Li G; Li J; Li W; Wei S; Vatan L; Zhang H; Szeliga W; Gu W; Liu R; Lawrence TS; Lamb C; Tanno Y; Cieslik M; Stone E; Georgiou G; Chan TA; Chinnaiyan A; Zou W
Nature; 2019 May; 569(7755):270-274. PubMed ID: 31043744
[TBL] [Abstract][Full Text] [Related]
17. Emerging roles of ferroptosis in the tumor immune landscape: from danger signals to anti-tumor immunity.
Shi L; Liu Y; Li M; Luo Z
FEBS J; 2022 Jul; 289(13):3655-3665. PubMed ID: 34042258
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis, radiotherapy, and combination therapeutic strategies.
Lei G; Mao C; Yan Y; Zhuang L; Gan B
Protein Cell; 2021 Nov; 12(11):836-857. PubMed ID: 33891303
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil ferroptosis causes immunosuppression.
Flemming A
Nat Rev Immunol; 2023 Jan; 23(1):6. PubMed ID: 36470969
[No Abstract] [Full Text] [Related]
20. The Ferroptosis Molecular Subtype Reveals Characteristics of the Tumor Microenvironment, Immunotherapeutic Response, and Prognosis in Gastric Cancer.
Xu X; Zhou N; Lan H; Yang F; Dong B; Zhang X
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
